Who Paid My Doc
Daniel Cooke
Neuroradiology San Francisco, CA Medical Doctor
NPI 1144334632 CMS profile 143015
505 Parnassus Ave, San Francisco, CA 94143
General payments
$63,094
Research payments
$25,277
Ownership & investment interest
$0
Research they led as principal investigator
$1,447,517
Through program year 2025, Daniel Cooke of San Francisco, CA is reported in the CMS Open Payments database as having received $63,094 across 216 general payments and $25,277 in research payments paid to them. Separately, studies naming them as principal investigator received $1,447,517 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Neuroradiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $12,381 | 41 | |
| 2025 | Research | $20,345 | 1 | |
| 2024 | General | $5,870 | 36 | |
| 2024 | Research | $4,932 | 1 | |
| 2023 | General | $15,702 | 48 | |
| 2022 | General | $4,092 | 16 | |
| 2021 | General | $14,922 | 28 | |
| 2020 | General | $6,856 | 15 | |
| 2019 | General | $3,271 | 32 |
Beside peers
- Daniel Cooke
- Neuroradiology median
- Middle half of Neuroradiology
- National median
In program year 2025, general payments to Daniel Cooke were reported at $12,381. Among 399 Neuroradiology profiles paid that year, the median was $279 and the middle half received between $65 and $2,205.
Show as a table
| Year | Daniel Cooke | Neuroradiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,271 | $288 | $71–$2,035 | $163 |
| 2020 | $6,856 | $165 | $32–$1,794 | $114 |
| 2021 | $14,922 | $238 | $42–$1,807 | $132 |
| 2022 | $4,092 | $191 | $49–$1,388 | $149 |
| 2023 | $15,702 | $228 | $56–$1,148 | $160 |
| 2024 | $5,870 | $241 | $97–$2,192 | $164 |
| 2025 | $12,381 | $279 | $65–$2,205 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 38 billing codesPaid by Medicare
$62,711
Medicare patients
83
Services billed
344
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 37% | |
| Chronic kidney disease | 36% | |
| Ischemic heart disease | 35% | |
| Depression | 30% | |
| Diabetes | 29% | |
| Cancer | 23% | |
| Atrial fibrillation | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
218 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Neuroradiology in California
Practitioners in the same specialty and state, ranked by reported value.
All Neuroradiology
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.